S. Seeber
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 43
- Colorectal Cancer Treatments and Studies 23
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 26
- Hematopoietic Stem Cell Transplantation 19
- Pulmonary and Respiratory Medicine top 0.5%
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 25
-
- Cancer therapeutics and mechanisms 31
-
- Acute Lymphoblastic Leukemia research 22
-
- Testicular diseases and treatments 20
- Co-authors
- A. HarstrickDirk StrumbergMartin StuschkeM. E. ScheulenH. WilkeU. VanhoeferJ. SchütteM. Stahl
- Journals
- Journal of Cancer Research and Clinical Oncology (30 papers)Annals of Oncology (16 papers)Journal of Clinical Oncology (12 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
S. Seeber
278 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 4.0k
- Hematology 1.4k
- Pulmonary and Respiratory Medicine 3.0k
- Genetics 846
- Pathology and Forensic Medicine 977
Countries citing papers authored by S. Seeber
This map shows the geographic impact of S. Seeber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Seeber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Seeber more than expected).
Fields of papers citing papers by S. Seeber
This network shows the impact of papers produced by S. Seeber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Seeber. The network helps show where S. Seeber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Seeber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 49 | |
| 2 | 2006 | 36 | |
| 3 | Free light-chain measurement in serum compared with immunofixation of urine in patients with multiple myeloma | 2003 | 2 |
| 4 | 2003 | 46 | |
| 5 | 2002 | 13 | |
| 6 | 2002 | 29 | |
| 7 | Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy. | 2001 | 30 |
| 8 | D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. | 2001 | 131 |
| 9 | Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. | 2000 | 38 |
| 10 | 2000 | 7 | |
| 11 | 1999 | 55 | |
| 12 | Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells. | 1997 | 5 |
| 13 | 1997 | 63 | |
| 14 | 1996 | 6 | |
| 15 | 1996 | 20 | |
| 16 | 1996 | 5 | |
| 17 | 1994 | 0 | |
| 18 | 1994 | 23 | |
| 19 | 1992 | 4 | |
| 20 | 1991 | 9 |
About S. Seeber
S. Seeber is a scholar working on Hematology, Oncology and Genetics, having authored 287 papers that have together received 9.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (43 papers), Cancer therapeutics and mechanisms (31 papers), Chronic Myeloid Leukemia Treatments (26 papers), Chronic Lymphocytic Leukemia Research (25 papers), Colorectal Cancer Treatments and Studies (23 papers), Acute Lymphoblastic Leukemia research (22 papers), Testicular diseases and treatments (20 papers) and Hematopoietic Stem Cell Transplantation (19 papers). The work is most often cited by research in Oncology (4.0k citations), Hematology (1.4k citations) and Pulmonary and Respiratory Medicine (3.0k citations). S. Seeber has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include A. Harstrick, Dirk Strumberg, Martin Stuschke, M. E. Scheulen, H. Wilke, U. Vanhoefer, J. Schütte, M. Stahl, Bertram Opalka and Michael Flaßhove. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Annals of Oncology, Journal of Clinical Oncology, Journal of Molecular Medicine and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.